Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Harrison

Showing results (51-60 of 261) with videos related to

Pageof 27
Sort By:
Clinicoeconomics and Outcomes Research : CEOR|September 24, 2014
Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid populationMachaon Bonafede, George J Joseph, Neel Shah, et al.
Journal of Managed Care & Specialty Pharmacy|December 3, 2014
Treatment patterns and annual drug costs of biologic therapies across indications from the Humana commercial databaseAndrew Howe, Laura Ten Eyck, Robert Dufour, et al.
BMC Cancer|July 10, 2008
TGFbeta induces apoptosis and EMT in primary mouse hepatocytes independently of p53, p21Cip1 or Rb statusSharon Sheahan, Christopher O Bellamy, Stephen N Harland, et al.
BMC Cancer|November 21, 2007
Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrestSharon Sheahan, Christopher O Bellamy, Donald R Dunbar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 2, 2011
Routinely obtained diagnostic material as a source of RNA for personalized medicine in lung cancer patientsTimothy D Andrews, Jan W Baird, William A H Wallace, et al.
Gigascience|October 23, 2025
SurGen: 1020 H&E-stained whole-slide images with survival and genetic markersCraig Myles, In Hwa Um, Craig Marshall, et al.
Journal of Clinical Pathology|July 9, 2016
Could molecular pathology testing in lung cancer be more cost-effective?Kathy Walsh, Yuan Chun Kheng, Anca Oniscu, et al.
Free Radical Biology & Medicine|February 14, 2002
Glutathione and p53 independently mediate responses against oxidative stress in ES cellsJonathan P Coe, Irfan Rahman, Nathalie Sphyris, et al.
Scientific Reports|October 28, 2015
Novel Monte Carlo approach quantifies data assemblage utility and reveals power of integrating molecular and clinical information for cancer prognosisWim Verleyen, Simon P Langdon, Dana Faratian, et al.
Vascular Health and Risk Management|December 22, 2018
Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitorsDionne M Hines, Pallavi Rane, Jeetvan Patel, et al.
Pageof 27

Showing results (51-60 of 261) with videos related to

Sort By:
Pageof 27
Clinicoeconomics and Outcomes Research : CEOR|September 24, 2014
Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid populationMachaon Bonafede, George J Joseph, Neel Shah, et al.
Journal of Managed Care & Specialty Pharmacy|December 3, 2014
Treatment patterns and annual drug costs of biologic therapies across indications from the Humana commercial databaseAndrew Howe, Laura Ten Eyck, Robert Dufour, et al.
BMC Cancer|July 10, 2008
TGFbeta induces apoptosis and EMT in primary mouse hepatocytes independently of p53, p21Cip1 or Rb statusSharon Sheahan, Christopher O Bellamy, Stephen N Harland, et al.
BMC Cancer|November 21, 2007
Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrestSharon Sheahan, Christopher O Bellamy, Donald R Dunbar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 2, 2011
Routinely obtained diagnostic material as a source of RNA for personalized medicine in lung cancer patientsTimothy D Andrews, Jan W Baird, William A H Wallace, et al.
Gigascience|October 23, 2025
SurGen: 1020 H&E-stained whole-slide images with survival and genetic markersCraig Myles, In Hwa Um, Craig Marshall, et al.
Journal of Clinical Pathology|July 9, 2016
Could molecular pathology testing in lung cancer be more cost-effective?Kathy Walsh, Yuan Chun Kheng, Anca Oniscu, et al.
Free Radical Biology & Medicine|February 14, 2002
Glutathione and p53 independently mediate responses against oxidative stress in ES cellsJonathan P Coe, Irfan Rahman, Nathalie Sphyris, et al.
Scientific Reports|October 28, 2015
Novel Monte Carlo approach quantifies data assemblage utility and reveals power of integrating molecular and clinical information for cancer prognosisWim Verleyen, Simon P Langdon, Dana Faratian, et al.
Vascular Health and Risk Management|December 22, 2018
Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitorsDionne M Hines, Pallavi Rane, Jeetvan Patel, et al.
Pageof 27